CBD, a chemical compound found in marijuana, has some medicinal effects and may be utilized to treat various conditions.
The FDA is concerned about products sold as dietary supplements or food additives containing CBD that have not been cleared by the agency for therapeutic use. They may not be safe or effective and pose a risk to public health.
Corticobasal Degeneration (CBD) is a rare disorder that affects the front and temporal lobes of your brain. This part of your mind controls thought, movement, speech and memory.
Neurofibrillary tangles are caused by abnormal clusters of tau protein in your brain cells. These clumps form neurofibrillary tangles which break down brain cells.
Doctors may suspect CBD when someone exhibits symptoms like stiffness, slowness of movements and tremor. It could also cause issues with balance and coordination as well as difficulties speaking and memory.
Drugs typically don’t work to treat Parkinson’s disease, but some therapies may help manage symptoms. These include occupational and physical therapy which can assist you with daily tasks.
Diagnosing CBD is based on clinical symptoms, autopsy findings and advanced neuroimaging. Typically, the underlying pathology can be identified through the presence of swollen or ballooned nerve cells in the cortex and substantia nigra.
Nonfluent/agrammatic variant of primary progressive aphasia
Primary Progressive Aphasia (PPA) is a group of brain disorders that impact the areas responsible for speech and language processing
The primary symptom of PPA is an increasingly severe loss of language comprehension and speech. Other problems may also develop as the disease progresses, such as depression or other mental health concerns.
Researchers have distinguished three distinct types of PPA: nonfluent/agrammatic variant (naPPA), semantic variant (svPPA) and logopenic variant (lvPPA). Each variant was identified based on its distinct symptom profile to help doctors diagnose the condition.
The nonfluent/agrammatic variant of primary progressive aphasia is characterized by an absence of fluency in speech and difficulty understanding grammatical elements of language. Though there are believed to be various causes for this disorder, scientists still don’t know exactly how or why some individuals experience it.
Parkinson’s disease (PD) occurs when nerve cells in the brain fail to produce enough of a chemical known as dopamine. This cell loss can occur in an area called the substantia nigra (sub-STAN-she-uh NYE-gruh).
Though the exact cause of why some people develop this condition while others do not is still unknown, it is believed that exposure to certain chemicals in the environment may play a role.
Treatment for Parkinson’s includes medications that raise dopamine levels in the brain. These agents work by crossing over the blood-brain barrier and turning into dopamine in the substantia nigra, or nogular brain area.
Levodopa is the most effective drug for treating Parkinson’s disease. It helps restore dopamine levels and is usually given along with carbidopa, which increases levodopa’s availability across the blood-brain barrier.
Other medications can be used for symptoms such as tremor and rigidity. Although less effective than levodopa, they may help reduce side effects. Examples include dopamine agonists and anticholinergics.
Alzheimer’s disease is a devastating disorder that causes memory loss and other problems. It develops due to an accumulation of two proteins inside and around brain cells; these build up into plaques and tangles inside the cerebral cortex.
These changes occur years before symptoms of dementia (thinking and memory problems) appear. They affect areas of the brain involved in learning and memory as well as language, behavior, and other skills.
Everyone experiences occasional memory lapses, but those living with Alzheimer’s typically experience persistent and serious memory problems that worsen over time. They may forget names of family members or familiar objects; additionally, they may repeat statements or questions repeatedly.
Doctors diagnose Alzheimer’s through a combination of medical and cognitive tests. They may also perform a brain scan or lab test on spinal fluid to look for signs of the disease.